68Ga-DOTA-MGS5

68Ga-DOTA-MGS5 · Medical University Innsbruck

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-DOTA-MGS5, covering 2023-12-05 to 2023-12-05. Get the full timeline:

Most recent: Clinical Trial Update: 68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours [Phase 1, Phase 2]